Samsung’s system chip head says M&As needed for non-memory goal, page-4

BRN including myself and fellow company shareholders hold a patent that is unique.

Bring into the fold for consideration pharmaceuticals that also have unique patents. (they have not sold and are massive 1st rate company leaders)

I for one do not have the full understanding of this way over my head technology, I do however understand that basics, should a company produce groundbreaking product / advanced tech in this scenario / solid legally binding patent and already have strong links via collaboration with eg NASSA and other companies, plus already defined solid talks with other companies on the table (whom knows what and if contracts have already been signed, there already creates a problem)

purely something to think about.

So looking forward to an announcement like the rest of my fellow mushrooms company owners / shareholders